Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Avacta Group, Electrocore, Fio, Mel-Mont Medical, Mighty Oak Medical, Neuropace, Orthopediatrics, Relay Medical, Speedx.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abl, Advita, Aldeyra, Arcturus, Bausch, BMS, CSL, Cytodyn, Marinus, Medexus, Moderna, Monopar, Novartis, Panther, Pharmather, Relief, Roche, UCB.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allegro, Ambrx, Angion, Antibe, Eli Lilly, Evotec, Fate, Jacobio, Janssen, Kiniksa, Lumosa, Lutris, Rhythm, Springworks.
Investigators at the University of California at San Francisco have identified a confounder that appears to be behind the purported anti-SARS-CoV-2 effects of a number of therapeutic candidates that were identified via repurposing.
LONDON – The U.K. has set up the first randomized controlled trial of COVID-19 vaccines in pregnant women, to assess different dosing schedules. The aim is to find the balance between longer intervals that are known to spur a greater immune response, against shorter intervals that provide faster protection.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Experien Group, GE Healthcare, Haliodx, Mindmed, Modivcare, Northstar Medical Radioisotopes, Resolve Bioscience, Sorrento Therapeutics, Veracyte, Veranex, VRI Intermediate Holdings, Zeiss.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Ancilia, Burning, China Grand Pharmaceutical, Etherna, GT, Impact, Innocan, Insilico, Sanotize, Takeda, Westlake.
RSS
